Both in Pharmaceuticals
Lifevantage Corporation Common Stock (Delaware) vs Medicinova
Over the past year LFVN returned −21.5% and MNOV returned −5.3%; their daily moves had a correlation of 0.04.
LFVN −21.5% MNOV −5.3%Growth of $1, one year, split-adjusted
| Metric | LFVN | MNOV |
|---|---|---|
| Price | $5.76 | $1.42 |
| Market cap | $72.5M | $69.9M |
| Today | −1.87% | −1.39% |
| 1 month | −4.5% | −19.1% |
| 6 months | +4.9% | +0.7% |
| Year to date | −6.5% | +8.4% |
| 1 year | −29.7% | −14.5% |
| Revenue growth (YoY) | −23.1% | +240.6% |
| Gross margin | 78.0% | 100.0% |
| Net margin | 3.0% | −504.8% |
| P/E (TTM) | 14.3× | — |
| Price / sales | 0.4× | 75.9× |
| Net cash | $14.9M | $25.4M |
| Dividend yield | 3.47% | — |
| Volatility (60d) | 24.9% | 114.5% |
| Short % of float | 9.5% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).